Molbio Diagnostics.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
One to three months ago
-
The World Health Organization endorsed new TB diagnostics developed by Molbio Diagnostics.Some support2 reports
-
Molbio Diagnostics' share price dropped 2% despite profit growth, while the company also completed a manufacturing capacity expansion program.Some support1 report
-
Both Molbio Diagnostics and Tempsens showed strong IPO performance on August 1, 2026.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Molbio Diagnostics this week
News at the entities that move Molbio Diagnostics most-
Goldman Sachs TransactionalAnalysts from Goldman Sachs, Wedbush Securities, and Bryson provided varied views on SanDisk's outlook.Moves Molbio Diagnostics
-
International Finance Corporation TransactionalADB and IFC join financing for Pakistan's Reko Diq mining project, with Islamabad as the policy seat.Moves Molbio Diagnostics
-
World Health Organization StructuralPrivate Sector Health Alliance of Nigeria and WHO called for increased private investment in health.Moves Molbio Diagnostics
-
Bengaluru StructuralLeader of Opposition criticized local government spending in Bengaluru.Moves Molbio Diagnostics
-
Motilal Oswal Mentioned togetherMotilal Oswal provided a Neutral rating for IndusInd Bank on November 20, 2026.Moves Molbio Diagnostics
-
Motilal Oswal Group Mentioned togetherMotilal Oswal Group registered a new AIF with SEBI and announced investment targets across several major Indian cities.Moves Molbio Diagnostics
Connections
The 12 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Goldman Sachs Transactional
Goldman Sachs invested in Molbio Diagnostics during its Initial Public Offering.
-
International Finance Corporation Transactional
IFC invested in Molbio Diagnostics during its Initial Public Offering.
-
Tempsens Mentioned together
Both companies were noted for exhibiting strong performance during their IPOs.
-
Africa Shared context
Molbio Diagnostics operates within the geographical and market context of the African continent.
-
World Health Organization Structural
The World Health Organization formally endorsed TB diagnostics produced by Molbio Diagnostics.
-
Bengaluru Structural
Molbio Diagnostics is establishing an R&D facility within the geographical boundaries of Bengaluru.
-
Motilal Oswal Mentioned together
Molbio Diagnostics is co-mentioned with Motilal Oswal in articles discussing its IPO launch.
-
Motilal Oswal Group Mentioned together
Co-mentioned in the context of fund management activities of Motilal Oswal Group.
Show all 12 connections
-
Goa Shared context
Molbio Diagnostics is located in the state of Goa.
-
Southeast Asia Shared context
Molbio Diagnostics is operating within the geographical context of Southeast Asia.
-
Latin America Shared context
Molbio Diagnostics operates within the regulatory context of Latin America.
-
GMP Mentioned together
Evidence is insufficient to establish a relationship between Molbio Diagnostics and GMP; only GMP's IPO interest was noted.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
3 events- Both Molbio Diagnostics and Tempsens showed strong IPO performance on August 1, 2026.
- Goldman Sachs, the International Finance Corporation, and Motilal Oswal Group are involved in the Initial Public Offering of Molbio Diagnostics.
- Molbio Diagnostics launched its IPO on August 5, 2026, alongside the Dhoot Transmission issue.